Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

Adlai Nortye announced clinical trial collaboration and supply agreements with Eli Lilly and Merck KGaA, Darmstadt, Germany to evaluate AN4035, a first-in-class pan-RAS(ON) inhibitor-based ADC, in combination with cetuximab in an ongoing global Phase I trial for CEACAM5-enriched RAS-addicted solid tumors. Both companies will supply cetuximab at no cost for their respective trial sites.

10/15/2026, 7:00 AM • GlobeNewswire

Global Oligonucleotide Synthesis Reagents Market Size, Share, and Forecast, 2026-2033 | Therapeutics Demand Fuels 11.9% CAGR and USD 1.75 Billion Opportunity

The global oligonucleotide synthesis reagents market is valued at USD 723.3 million in 2025 and is projected to reach USD 1.75 billion by 2033, growing at a 11.9% CAGR. Growth is driven by increasing demand for nucleic acid-based therapeutics including siRNA, antisense oligonucleotides, CRISPR gene editing, and mRNA platforms across oncology, rare genetic disorders, and infectious diseases.

10/05/2026, 6:44 AM • GlobeNewswire

Cell and Gene Therapy Biomanufacturing Market - Size, Share, and Forecast, 2026-2031 | Automation, Viral Vectors, and CDMO Expansion Drive 11.7% CAGR to $8.7 Billion

The global cell and gene therapy biomanufacturing market is projected to grow from $5.0 billion in 2026 to $8.7 billion by 2031, driven by an 11.7% CAGR. Growth is fueled by increasing regulatory approvals, rising demand for scalable manufacturing infrastructure, and investments in automation and modular systems. However, high production costs, regulatory complexity, and workforce shortages remain significant challenges.

10/05/2026, 5:58 AM • GlobeNewswire

Magnetic Beads Market - Global Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion

The global magnetic beads market is projected to grow from USD 3.90 billion in 2026 to USD 6.18 billion by 2032, driven by automation, molecular diagnostics, genomics, and bioprocessing applications. Key growth drivers include adoption of automated magnetic separation platforms, advanced surface chemistries, AI-enabled workflow optimization, and expanding diagnostics capacity across regions. Strategic priorities for industry leaders include developing application-specific chemistries, strengthening supply-chain resilience, and leveraging AI analytics.

10/05/2026, 4:58 AM • GlobeNewswire

Moisture Absorber Market - Global Forecast 2026-2032 | Market to Reach USD 2.7 Billion at 7.59% CAGR as E-Commerce, Sustainable Packaging, and Supply Chain Resilience Drive Demand

The global moisture absorber market is projected to grow from USD 1.74 billion in 2026 to USD 2.70 billion by 2032 at a 7.59% CAGR, driven by e-commerce expansion, sustainable packaging demands, and supply chain resilience needs. The industry is shifting toward integrated humidity-control solutions with AI-assisted product optimization, sensor integration, and application-specific innovations across residential, commercial, and industrial sectors.

10/05/2026, 4:57 AM • GlobeNewswire

Global Methyl Grignard Reagent Market - Strategic Forecast, 2026-2032 | Pharmaceutical Demand, AI Process Control, and Resilient Supply Chains Unlock Growth Opportunities

The global methyl Grignard reagent market is experiencing growth driven by pharmaceutical demand, AI-enabled process control, and resilient supply chains. The market emphasizes safety, quality consistency, and reliable supply across regions, with AI tools improving research and manufacturing operations while maintaining expert oversight. Regional strategies vary based on local infrastructure, regulatory requirements, and technical capabilities.

10/05/2026, 4:51 AM • GlobeNewswire

Continuous Bioprocessing Technologies Market - Global Forecast 2026-2031 | Market to Reach USD 8.5 Billion as Automation and Biologics Demand Fuel 12.1% CAGR

The global continuous bioprocessing technologies market is projected to grow from USD 4.8 billion in 2026 to USD 8.5 billion by 2031, driven by rising biologics demand, regulatory support, and the biopharmaceutical industry's shift from batch to continuous production. Key growth drivers include cost efficiency, improved quality, and faster time to market, though high capital investment and technical complexity remain challenges.

10/01/2026, 11:00 AM • GlobeNewswire

Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers

Hummingbird Bioscience announced that HMBD-001, an anti-HER3 monoclonal antibody developed using its AI Molecular Medicine platform, has advanced into Phase II clinical trials for advanced squamous cell cancers in combination with cetuximab. The first patient has been dosed in the HMBD-001-103 study, with recommended doses identified based on safety, tolerability, and preliminary efficacy data. The advancement demonstrates the company's AI-first approach to drug discovery and development.

09/30/2026, 5:00 AM • GlobeNewswire

Magnetic Bead Purification Kits Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook

The global magnetic bead purification kits market reached $4.08 billion in 2025 with an 11.6% CAGR and is projected to grow to $6.73 billion by 2030 (10.5% CAGR) and $10.42 billion by 2035 (9.1% CAGR). Growth is driven by expanding genomics research, molecular diagnostics, and high-throughput screening. Semi-automated kits dominate at 51.8% market share, while Asia-Pacific is the fastest-growing region at 12% CAGR. Key challenges include skilled labor shortages and automation infrastructure dependencies.

09/21/2026, 4:56 AM • GlobeNewswire

Autoimmune Disease Therapeutics Market Set for Growth Through 2034 as Biologics, Precision Medicine and Pipeline Innovation Reshape the Competitive Landscape

The global autoimmune disease therapeutics market is projected to grow from USD 132.75 billion in 2025 to USD 254.60 billion by 2034, at a CAGR of 7.5%. Growth is driven by rising autoimmune disease diagnoses, increased adoption of biologics and targeted oral therapies, biosimilar expansion, and emerging cell and gene therapies. Biologics dominate with 66% market share, TNF inhibitors lead drug classes at 29%, and rheumatoid arthritis accounts for 34% of revenue. North America holds 44% regional share while Asia-Pacific is expected to grow fastest.

09/17/2026, 6:49 AM • GlobeNewswire

Bioprocess Automation Market Poised for Robust Growth Through 2033, Driven by Demand for Efficient, Scalable Biomanufacturing

The global bioprocess automation market is projected to grow from USD 8.6 billion in 2025 to USD 22.2 billion by 2033, expanding at a CAGR of 12.8%. Growth is driven by rising demand for biologics, advances in AI and robotics, and pressure to improve manufacturing efficiency and regulatory compliance. Automation technologies enhance throughput, consistency, and cost-effectiveness while reducing errors and production time.

09/15/2026, 5:57 AM • GlobeNewswire

Correction: Bioprinting Market to Reach $5.1 Billion by 2030, Driven by Regenerative Medicine Demand and AI Integration

The global bioprinting market is projected to grow from $2.1 billion in 2024 to $5.1 billion by 2030 at a 16.1% CAGR, driven by regenerative medicine demand, pharmaceutical adoption for drug discovery, reduced animal testing, and AI integration. North America leads with 38% market share, while emerging technologies like 4D bioprinting and organ-on-chip devices expand market boundaries.

08/27/2026, 7:51 AM • GlobeNewswire

[Latest] Global gRNA Market Size/Share Worth USD 2950 Million by 2034 at a 19% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

The global gRNA (guide RNA) market is projected to grow from USD 518 million in 2024 to USD 2,950 million by 2034, representing a 19% CAGR. Growth is driven by increasing cancer research, infectious disease prevalence, technological innovation, and expanding applications in genome editing, functional genomics, diagnostics, cell & gene therapy, and agricultural biotechnology. Key market players include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, and others. Strategic partnerships and rising adoption of CRISPR technology in agriculture are major growth catalysts.

08/06/2026, 5:30 PM • GlobeNewswire

[Latest] Global Deep Eutectic Solvents Market Size/Share Worth USD 735.89 Million by 2034 at a 15.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

The global Deep Eutectic Solvents (DES) market is projected to grow from USD 177.64 million in 2024 to USD 735.89 million by 2034, at a CAGR of 15.27%. Growth is driven by increasing demand for sustainable, eco-friendly alternatives to conventional solvents across pharmaceuticals, food processing, and chemical industries. Key players include Proionic GmbH, Merck KGaA, BASF SE, Thermo Fisher Scientific, and Solvay S.A.

08/05/2026, 3:30 PM • GlobeNewswire

Pyridine & Pyridine Derivatives Market Size to Reach USD 1,255.74 Million by 2035 on Rising Agrochemical and Pharma Demand | SNS Insider

The global Pyridine & Pyridine Derivatives Market is projected to grow from USD 812.04 million in 2025 to USD 1,255.74 million by 2035, at a CAGR of 4.97%. Growth is driven by increasing demand from agrochemical and pharmaceutical industries, with pyridine leading product segments and herbicides dominating applications. Asia Pacific holds the largest market share at 48%, while the U.S. market is expected to reach USD 228.10 million by 2035.

07/23/2026, 6:47 AM • GlobeNewswire